Lupin (LUPIN) — Announcement

Lupin disclosed that its US subsidiary Lupin Inc. converted a $41 million loan plus $3.3 million interest to equity in Lupin Oncology Inc., making it a step-down subsidiary. The transaction increased Lupin’s effective stake in LOI to 99.87% and reflects a related party conversion at arm’s length with no regulatory approvals required.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this announcement affect Lupin Limited's outlook?" "What did Lupin Limited announce on 23 May 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 23 May 2025

SHRIRAMFIN Shriram Finance Limited Corporate Action SHRIRAMFIN Shriram Finance Limited Corporate Action SHRIRAMFIN Shriram Finance Limited Corporate Action TORNTPHARM Torrent Pharmaceuticals Limited Financial Results WIPRO Wipro Limited Annual Report BAJAJ-AUTO Bajaj Auto Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.